Squire Matthew Stead

Title: Squire Matthew Stead: Innovator in Epilepsy Treatment Technologies

Introduction

Squire Matthew Stead is a notable inventor based in Bozeman, MT (US). He has made significant contributions to the field of medical technology, particularly in the treatment of epilepsy. With a total of 3 patents, his work focuses on advanced therapy systems that utilize quantified biomarker targeting.

Latest Patents

One of his latest patents is titled "Therapy systems with quantified biomarker targeting, including for epilepsy treatment, and associated systems and methods." This innovative approach involves a computer-based method for establishing treatment parameters for epilepsy patients. The method includes receiving multiple indications of interictal EEG biomarkers over time and processing these indications to produce a processed biomarker. This processed biomarker is then used to identify target locations in the patient's brain for delivering electrical therapy signals aimed at reducing or eliminating epileptic activity.

Another significant patent is related to "Multiscale brain electrode devices and methods for using the multiscale brain electrodes." These electrodes are designed for spatiotemporal mapping, probing, and therapeutic modulation of the human brain. The applications of this technology extend to neurological and psychiatric diseases, as well as brain rehabilitation.

Career Highlights

Squire Matthew Stead has worked with prominent organizations such as the Mayo Foundation for Medical Education and Research and Cadence Neuroscience, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas in medical technology.

Collaborations

Throughout his career, Squire has collaborated with esteemed colleagues, including Gregory A. Worrell and Benjamin H. Brinkmann. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Squire Matthew Stead is a pioneering inventor whose work in epilepsy treatment technologies has the potential to significantly improve patient outcomes. His innovative patents and collaborations highlight his commitment to advancing medical science and technology.